vs
Side-by-side financial comparison of PARK AEROSPACE CORP (PKE) and Spero Therapeutics, Inc. (SPRO). Click either name above to swap in a different company.
PARK AEROSPACE CORP is the larger business by last-quarter revenue ($17.3M vs $12.6M, roughly 1.4× Spero Therapeutics, Inc.). Spero Therapeutics, Inc. runs the higher net margin — 250.7% vs 17.0%, a 233.7% gap on every dollar of revenue. On growth, Spero Therapeutics, Inc. posted the faster year-over-year revenue change (24080.8% vs 20.3%). Over the past eight quarters, Spero Therapeutics, Inc.'s revenue compounded faster (847.7% CAGR vs 3.0%).
Park Electrochemical Corp, now called the Park Aerospace Corp, is a Melville, New York-based materials manufacturer for the telecommunications, Internet infrastructure, high-end computing, and aerospace industries. It produces high-technology digital and radio frequency(RF)/microwave printed circuit material products, composite materials. Its printed circuit materials are used for complex multilayer printed circuit boards and other electronic interconnection systems, such as multilayer back-p...
PKE vs SPRO — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $17.3M | $12.6M |
| Net Profit | $3.0M | $31.5M |
| Gross Margin | 34.1% | — |
| Operating Margin | 21.0% | — |
| Net Margin | 17.0% | 250.7% |
| Revenue YoY | 20.3% | 24080.8% |
| Net Profit YoY | 87.1% | 250.9% |
| EPS (diluted) | $0.15 | $0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $17.3M | $12.6M | ||
| Q3 25 | $16.4M | $0 | ||
| Q2 25 | $15.4M | $0 | ||
| Q1 25 | $16.9M | $12.0K | ||
| Q4 24 | $14.4M | $52.0K | ||
| Q3 24 | $16.7M | $65.0K | ||
| Q2 24 | $14.0M | $114.0K | ||
| Q1 24 | $16.3M | $140.0K |
| Q4 25 | $3.0M | $31.5M | ||
| Q3 25 | $2.4M | $-7.4M | ||
| Q2 25 | $2.1M | $-1.7M | ||
| Q1 25 | $1.2M | $-13.9M | ||
| Q4 24 | $1.6M | — | ||
| Q3 24 | $2.1M | $-17.1M | ||
| Q2 24 | $993.0K | $-17.9M | ||
| Q1 24 | $2.7M | $-12.7M |
| Q4 25 | 34.1% | — | ||
| Q3 25 | 31.2% | — | ||
| Q2 25 | 30.6% | — | ||
| Q1 25 | 29.3% | — | ||
| Q4 24 | 26.6% | — | ||
| Q3 24 | 28.5% | — | ||
| Q2 24 | 29.3% | — | ||
| Q1 24 | 27.3% | — |
| Q4 25 | 21.0% | — | ||
| Q3 25 | 17.4% | — | ||
| Q2 25 | 15.7% | — | ||
| Q1 25 | 16.8% | -122758.3% | ||
| Q4 24 | 12.8% | — | ||
| Q3 24 | 15.7% | -28604.6% | ||
| Q2 24 | 14.9% | -16720.2% | ||
| Q1 24 | 15.7% | -9987.1% |
| Q4 25 | 17.0% | 250.7% | ||
| Q3 25 | 14.7% | — | ||
| Q2 25 | 13.5% | — | ||
| Q1 25 | 7.4% | -115550.0% | ||
| Q4 24 | 10.9% | — | ||
| Q3 24 | 12.4% | -26380.0% | ||
| Q2 24 | 7.1% | -15668.4% | ||
| Q1 24 | 16.3% | -9049.3% |
| Q4 25 | $0.15 | $0.56 | ||
| Q3 25 | $0.12 | $-0.13 | ||
| Q2 25 | $0.10 | $-0.03 | ||
| Q1 25 | $0.06 | $-0.25 | ||
| Q4 24 | $0.08 | — | ||
| Q3 24 | $0.10 | $-0.32 | ||
| Q2 24 | $0.05 | $-0.33 | ||
| Q1 24 | $0.13 | $-0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $63.6M | $40.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $106.6M | $59.0M |
| Total Assets | $118.1M | $68.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.6M | $40.3M | ||
| Q3 25 | $61.6M | $48.6M | ||
| Q2 25 | $65.6M | $31.2M | ||
| Q1 25 | $68.8M | $48.9M | ||
| Q4 24 | $70.0M | $52.9M | ||
| Q3 24 | $72.0M | $76.3M | ||
| Q2 24 | $74.4M | $63.5M | ||
| Q1 24 | $77.2M | $82.3M |
| Q4 25 | $106.6M | $59.0M | ||
| Q3 25 | $105.8M | $26.5M | ||
| Q2 25 | $105.0M | $32.8M | ||
| Q1 25 | $107.2M | $33.8M | ||
| Q4 24 | $107.4M | $46.1M | ||
| Q3 24 | $110.3M | $65.5M | ||
| Q2 24 | $111.7M | $80.5M | ||
| Q1 24 | $112.9M | $96.2M |
| Q4 25 | $118.1M | $68.9M | ||
| Q3 25 | $116.4M | $54.2M | ||
| Q2 25 | $120.7M | $62.1M | ||
| Q1 25 | $122.1M | $77.7M | ||
| Q4 24 | $124.2M | $110.5M | ||
| Q3 24 | $125.1M | $135.2M | ||
| Q2 24 | $129.4M | $149.9M | ||
| Q1 24 | $132.3M | $167.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $5.1M | $-8.4M |
| Free Cash FlowOCF − Capex | $4.3M | — |
| FCF MarginFCF / Revenue | 24.6% | — |
| Capex IntensityCapex / Revenue | 4.8% | — |
| Cash ConversionOCF / Net Profit | 1.73× | -0.26× |
| TTM Free Cash FlowTrailing 4 quarters | $3.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.1M | $-8.4M | ||
| Q3 25 | $-2.1M | $17.4M | ||
| Q2 25 | $1.6M | $-17.7M | ||
| Q1 25 | $969.0K | $-4.0M | ||
| Q4 24 | $2.7M | $-23.4M | ||
| Q3 24 | $1.4M | $12.8M | ||
| Q2 24 | $-423.0K | $-18.7M | ||
| Q1 24 | $5.3M | $5.9M |
| Q4 25 | $4.3M | — | ||
| Q3 25 | $-2.3M | — | ||
| Q2 25 | $1.1M | — | ||
| Q1 25 | $338.0K | — | ||
| Q4 24 | $2.7M | — | ||
| Q3 24 | $1.3M | — | ||
| Q2 24 | $-435.0K | — | ||
| Q1 24 | $5.1M | — |
| Q4 25 | 24.6% | — | ||
| Q3 25 | -14.0% | — | ||
| Q2 25 | 7.2% | — | ||
| Q1 25 | 2.0% | — | ||
| Q4 24 | 18.6% | — | ||
| Q3 24 | 7.5% | — | ||
| Q2 24 | -3.1% | — | ||
| Q1 24 | 31.4% | — |
| Q4 25 | 4.8% | — | ||
| Q3 25 | 1.1% | — | ||
| Q2 25 | 3.1% | — | ||
| Q1 25 | 3.7% | — | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | 1.2% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 1.0% | — |
| Q4 25 | 1.73× | -0.26× | ||
| Q3 25 | -0.88× | — | ||
| Q2 25 | 0.76× | — | ||
| Q1 25 | 0.78× | — | ||
| Q4 24 | 1.73× | — | ||
| Q3 24 | 0.70× | — | ||
| Q2 24 | -0.43× | — | ||
| Q1 24 | 1.98× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PKE
| North America | $16.8M | 97% |
| Other | $546.0K | 3% |
SPRO
Segment breakdown not available.
